Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record presents details of a completed phase II trial evaluating sorafenib and nivolumab for advanced liver cancer, including its results, participant criteria, and study documents.
    Difference
    77%
    Check dated 2026-11-07T11:58:43.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:45:35.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T12:27:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:50:09.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The 403 error page displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T13:17:55.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected content with an access-denied screen while the site chrome (navigation and footer) remains visible.
    Difference
    23%
    Check dated 2026-09-19T18:22:41.000Z thumbnail image

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.